Overall Survival and Progression-Free Survival of Patients Following Luspatercept Treatment in the MEDALIST Trial

被引：2

作者：

Santini, Valeria ^{[1
]}

Fenaux, Pierre ^{[2
]}

Zeidan, Amer M. ^{[3
,4
]}

Komrokji, Rami S. ^{[5
]}

Buckstein, Rena ^{[6
]}

Oliva, Esther Natalie ^{[7
]}

Ha, Xianwei ^{[8
]}

Miteva, Dimana ^{[9
]}

Yucel, Aylin ^{[8
]}

Nadal, Jose Alberto ^{[9
]}

Platzbecker, Uwe ^{[10
]}

机构：

[1] Univ Florence, Florence, Italy

[2] Hop St Louis, Assistance Publ Hop Paris AP HP, Paris, France

[3] Yale Univ, Yale Sch Med, New Haven, CT USA

[4] Yale Univ, Yale Canc Ctr, New Haven, CT USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[6] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada

[7] Grande Osped Metropolitano Bianchi Melacrino More, Reggio Di Calabria, Italy

[8] Bristol Myers Squibb, Princeton, NJ USA

[9] Bristol Myers Squibb Co, Celgene Int Sarl, Boudry, Switzerland

[10] Univ Leipzig, Med Ctr, Dept Hematol Cell Therapy & Hemostaseol, Leipzig, Germany

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-157489

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4079 / 4081

页数：3

共 50 条

[11] Progression-free survival as a surrogate for overall survival in advanced cancer.
Gillies, Eric
Holdai, Veera
Cowall, David Eric
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[12] OVERALL SURVIVAL VERSUS PROGRESSION-FREE SURVIVAL IN ONCOLOGY CLINICAL TRIALS
Aissaoui, A.
Bin Sawad, A.
Turkistani, F.
Aissaoui, N.
VALUE IN HEALTH, 2016, 19 (07) : A717 - A717
[13] Progression-Free Survival as a Surrogate Marker of Overall Survival Is It the Good Question?
Escudier, Bernard
CANCER, 2011, 117 (12) : 2586 - 2587
[14] A statistical model for the dependence between progression-free survival and overall survival
Fleischer, Frank
Gaschler-Markefski, Birgit
Bluhmki, Erich
STATISTICS IN MEDICINE, 2009, 28 (21) : 2669 - 2686
[15] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
Beauchemin, C.
Cooper, D.
Lapierre, M.
Yelle, L.
Lachaine, J.
ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
[16] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
Beauchemin, C.
Cooper, D.
Lapierre, M. E.
Yelle, L.
Lachaine, J.
VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
[17] Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
Broglio, Kristine R.
Berry, Donald A.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (23): : 1642 - 1649
[18] Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients
Hogdall, Estrid
Fung, Eric T.
Christensen, Ib Jarle
Yip, Christine
Nedergaard, Lotte
Engelholm, Svend Aage
Risum, Signe
Petri, Anette Lykke
Lundvall, Lene
Lomas, Lee
Hogdall, Claus
PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (12) : 940 - 952
[19] EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
Bramuzzo, I.
Gerussi, A.
Maier, S.
Bianco, C.
Romanin, A.
Pasini, C. Laghi
Barghini, V.
Scata, L.
Donnini, D.
Uzzau, A.
Vit, A.
Sechi, L. A.
Soardo, G.
DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E217 - E217
[20] Long-term outcomes in the PRIMA trial: a closer look at progression-free survival and overall survival
Wu, T.
Zhang, P.
Wang, G.
ANNALS OF ONCOLOGY, 2025, 36 (03) : 340 - 340

← 1 2 3 4 5 →